All Articles

Mission Produce aims to double sales by 2035, but can its massive Calavo Growers integration and shift to prepared foods survive commodity market volatility?

A new three-tier triage framework aims to protect prostate cancer patients from the lethal cardiovascular risks of life-extending hormone therapies.

Jack Patterson investigates how a new complimentary orthodontic program in Georgia exposes and bypasses systemic gaps in craniofacial healthcare coverage.

CytoDyn is pivoting to oncology with its CCR5 inhibitor leronlimab. Upcoming Phase 2 data at ESMO 2026 could determine the biotech's financial survival.

A sharp rise in September CUSIP identifier requests points to an unfreezing IPO pipeline and strategic corporate debt issuance ahead of an active fourth quarter.

As AI moves from the cloud to the factory floor, enterprises face a billion-dollar question: how to buy hardware that won't be obsolete in six months.

Sanas introduces a hybrid AI model turning call center reps into bot supervisors. Will managing four concurrent calls elevate workers or accelerate burnout?

As GPS jamming threatens everything from military comms to the financial grid, NAL Technologies offers a drop-in antenna that could save billions.

As generative AI hype cools, legal tech incumbent Litera is restructuring its C-suite to solve enterprise software's biggest bottleneck: actual user adoption.

Accion Opportunity Fund's new report reveals a 112-to-1 economic multiplier, but the real story lies in crypto equity and a 96% small business survival rate.

By combining workplace insights with Indeed's massive job marketplace, Glassdoor's new matching tool wants to end job board fatigue and ghosting for good.

As AI-driven attacks compress breach timelines, Artemis Security's new Orion-1 model bets that autonomous, agentic defense is the only viable response.

As return-to-office friction mounts, a new tripartite alliance blends agentic AI, physical logistics, and facilities management to fix the corporate workplace.

A breakthrough gene therapy restores natural hearing in children, challenging mechanical implants and reshaping the economics of genomic medicine.

With a new $125M Series D, Medical Microinstruments is moving robotics into the sub-millimeter realm, targeting lymphatic repair and Alzheimer's disease.

Veriff's top ranking on G2 highlights a massive shift in KYC compliance. Address checks are no longer just about mail—they are frontline fraud shields.

The AMA's Category I CPT code approval for Vektor Medical's vMap signals a major shift, turning computational ECGs into commercial reality.

As AI moves from pilot to production, ISO 42001 certification has become the mandatory baseline for enterprise trust and vendor procurement.

As Medicare's Annual Enrollment Period begins, new data reveals that administrative complexity and rising costs are pushing seniors to skip essential medical care.

As humanoids and drones scale up, the EU's strict new Cyber Resilience Act is forcing manufacturers to secure our physical world in real time.